Sodium Bicarbonate → HCID 136132157, 화합물

HRID 566364노트

반응식

HRID 566364 반응식
[NH2:1][C:2]1[N:6]([CH:7]([CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH3:16])[CH2:8][CH2:9][CH3:10])[N:5]=[C:4]([CH2:17][CH2:18][CH3:19])[C:3]=1[C:20]([NH2:22])=[O:21].[Cl:23][C:24]1[CH:25]=[C:26]([CH2:31][C:32](OC)=O)[CH:27]=[CH:28][C:29]=1[Cl:30].[O-]CC.[Na+].C(=O)([O-])O.[Na+]>ClCCl>[Cl:23][C:24]1[CH:25]=[C:26]([CH:27]=[CH:28][C:29]=1[Cl:30])[CH2:31][C:32]1[NH:22][C:20](=[O:21])[C:3]2[C:4]([CH2:17][CH2:18][CH3:19])=[N:5][N:6]([CH:7]([CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH3:16])[CH2:8][CH2:9][CH3:10])[C:2]=2[N:1]=1

참가 물질

6

반응물 4

HCID 516892Sodium BicarbonateHCID 1268257Methyl 2-(3,4-dichlorophenyl)acetateHCID 2723922Sodium ethoxideHCID 59932330HCID 59932330, 화합물

생성물 1

HCID 136132157HCID 136132157, 화합물수율 55.1%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

10 mg (0.019 mmol) of 5-amino-3-propyl-1-(4-decyl)-1H-pyrazole-4-carboxamide and 20 mg (0.091 mmol) of methyl 3,4-dichlorophenylacetate are refluxed for 6 hours in 0.3 ml of a 0.5M ethanolic sodium ethoxide solution. After dichloromethane and saturated aqueous sodium hydrogen carbonate solution have been added, the phases are separated. Purification by chromatography gives 5 mg (48%) of a solid, Rf=0.70 (dichloromethane/methanol=15:1).

후처리

  1. customthe phases are separated
  2. customPurification by chromatography

출처 및 근거

ORD 기록
ord-e81c37462eea4f9ca7070e2dd88b9181
출처 데이터셋
uspto-grants-2001_01
특허 번호
US06174884B1

반응 노트

불러오는 중…